ADMA Biologics
ADMA
ADMA
365 hedge funds and large institutions have $3.84B invested in ADMA Biologics in 2025 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 152 increasing their positions, 106 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
365
Holders Change
+20
Holders Change %
+5.8%
% of All Funds
4.89%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
79
Increased
152
Reduced
106
Closed
55
Calls
$53M
Puts
$31.2M
Net Calls
+$21.8M
Net Calls Change
-$29.2M
Top Buyers
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$53.8M |
| 2 |
Two Sigma Advisers
New York
|
-$28.3M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$27.2M |
| 4 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
-$22M |
| 5 |
Two Sigma Investments
New York
|
-$19.2M |
